176 related articles for article (PubMed ID: 33540613)
1. Eukaryotic Translation Initiation Factor 4AI: A Potential Novel Target in Neuroblastoma.
Skofler C; Kleinegger F; Krassnig S; Birkl-Toeglhofer AM; Singer G; Till H; Benesch M; Cencic R; Porco JA; Pelletier J; Castellani C; Raicht A; Izycka-Swieszewska E; Czapiewski P; Haybaeck J
Cells; 2021 Feb; 10(2):. PubMed ID: 33540613
[TBL] [Abstract][Full Text] [Related]
2. Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
Kling MJ; Griggs CN; McIntyre EM; Alexander G; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
BMC Cancer; 2021 Sep; 21(1):1061. PubMed ID: 34565342
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation.
Rubio CA; Weisburd B; Holderfield M; Arias C; Fang E; DeRisi JL; Fanidi A
Genome Biol; 2014; 15(10):476. PubMed ID: 25273840
[TBL] [Abstract][Full Text] [Related]
4. miRNA-558 promotes tumorigenesis and aggressiveness of neuroblastoma cells through activating the transcription of heparanase.
Qu H; Zheng L; Pu J; Mei H; Xiang X; Zhao X; Li D; Li S; Mao L; Huang K; Tong Q
Hum Mol Genet; 2015 May; 24(9):2539-51. PubMed ID: 25616966
[TBL] [Abstract][Full Text] [Related]
5. Eukaryotic translation initiation factors as promising targets in cancer therapy.
Hao P; Yu J; Ward R; Liu Y; Hao Q; An S; Xu T
Cell Commun Signal; 2020 Nov; 18(1):175. PubMed ID: 33148274
[TBL] [Abstract][Full Text] [Related]
6. eIF4F: a retrospective.
Merrick WC
J Biol Chem; 2015 Oct; 290(40):24091-9. PubMed ID: 26324716
[TBL] [Abstract][Full Text] [Related]
7. Tideglusib attenuates growth of neuroblastoma cancer stem/progenitor cells in vitro and in vivo by specifically targeting GSK-3β.
Bahmad HF; Chalhoub RM; Harati H; Bou-Gharios J; Assi S; Ballout F; Monzer A; Msheik H; Araji T; Elajami MK; Ghanem P; Chamaa F; Kadara H; Abou-Antoun T; Daoud G; Fares Y; Abou-Kheir W
Pharmacol Rep; 2021 Feb; 73(1):211-226. PubMed ID: 33030673
[TBL] [Abstract][Full Text] [Related]
8. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
9. A cellular response linking eIF4AI activity to eIF4AII transcription.
Galicia-Vázquez G; Cencic R; Robert F; Agenor AQ; Pelletier J
RNA; 2012 Jul; 18(7):1373-84. PubMed ID: 22589333
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines.
Del Grosso F; De Mariano M; Passoni L; Luksch R; Tonini GP; Longo L
BMC Cancer; 2011 Dec; 11():525. PubMed ID: 22192458
[TBL] [Abstract][Full Text] [Related]
11. Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma.
Gheeya JS; Chen QR; Benjamin CD; Cheuk AT; Tsang P; Chung JY; Metaferia BB; Badgett TC; Johansson P; Wei JS; Hewitt SM; Khan J
Cancer Biol Ther; 2009 Dec; 8(24):2386-95. PubMed ID: 19946221
[TBL] [Abstract][Full Text] [Related]
12. Translation Initiation Machinery as a Tumor Selective Target for Radiosensitization.
Lehman SL; Wilson ED; Camphausen K; Tofilon PJ
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639005
[TBL] [Abstract][Full Text] [Related]
13. Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A.
Cencic R; Robert F; Galicia-Vázquez G; Malina A; Ravindar K; Somaiah R; Pierre P; Tanaka J; Deslongchamps P; Pelletier J
Blood Cancer J; 2013 Jul; 3(7):e128. PubMed ID: 23872707
[TBL] [Abstract][Full Text] [Related]
14. microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5'-untranslated region in neuroblastoma.
Qu H; Zheng L; Song H; Jiao W; Li D; Fang E; Wang X; Mei H; Pu J; Huang K; Tong Q
Oncotarget; 2016 Jun; 7(26):40657-40673. PubMed ID: 27276678
[TBL] [Abstract][Full Text] [Related]
15. Dehydroeffusol inhibits viability and epithelial-mesenchymal transition through the Hedgehog and Akt/mTOR signaling pathways in neuroblastoma cells.
He K; Duan G; Li Y
Eur J Pharmacol; 2018 Jun; 829():93-101. PubMed ID: 29665365
[TBL] [Abstract][Full Text] [Related]
16. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4A.
Chu J; Galicia-Vázquez G; Cencic R; Mills JR; Katigbak A; Porco JA; Pelletier J
Cell Rep; 2016 Jun; 15(11):2340-7. PubMed ID: 27239032
[TBL] [Abstract][Full Text] [Related]
18. Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas.
Oblinger JL; Burns SS; Akhmametyeva EM; Huang J; Pan L; Ren Y; Shen R; Miles-Markley B; Moberly AC; Kinghorn AD; Welling DB; Chang LS
Neuro Oncol; 2016 Sep; 18(9):1265-77. PubMed ID: 26951381
[TBL] [Abstract][Full Text] [Related]
19. MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation.
Delaidelli A; Negri GL; Jan A; Jansonius B; El-Naggar A; Lim JKM; Khan D; Oo HZ; Carnie CJ; Remke M; Maris JM; Leprivier G; Sorensen PH
Cell Death Differ; 2017 Sep; 24(9):1564-1576. PubMed ID: 28574509
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor effect of AZD8055 against neuroblastoma cells in vitro and in vivo.
Xu DQ; Toyoda H; Yuan XJ; Qi L; Chelakkot VS; Morimoto M; Hanaki R; Kihira K; Hori H; Komada Y; Hirayama M
Exp Cell Res; 2018 Apr; 365(2):177-184. PubMed ID: 29499203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
